The Association Between Intraoperative Compromised Intestinal Integrity and Postoperative Complications in Cancer Patients.


Journal

Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840

Informations de publication

Date de publication:
15 Jan 2024
Historique:
received: 04 01 2023
accepted: 17 12 2023
medline: 16 1 2024
pubmed: 16 1 2024
entrez: 15 1 2024
Statut: aheadofprint

Résumé

Because of perioperative splanchnic hypoperfusion, the gut wall becomes more permeable for intraluminal microbes to enter the splanchnic circulation, possibly contributing to development of complications. Hypoperfusion-related injured enterocytes release intestinal fatty acid binding protein (I-FABP) into plasma, which is used as proxy of intestinal integrity. This study investigates the occurrence of intestinal integrity loss during oncologic surgery, measured by I-FABP change. Secondary the relationship between compromised intestinal integrity, and related variables and complications were studied. Patients undergoing oncologic surgery from prospective cohort studies were included. Urine I-FABP samples were collected preoperatively (T0) and at wound closure (T1), and in a subgroup on Day 1 (D1) and Day 2 (D2) postoperatively. I-FABP dynamics were investigated and logistic regression analyses were performed to study the association between I-FABP levels and patient-related, surgical variables and complications. A total of 297 patients were included with median age of 70 years. Median I-FABP value increased from 80.0 pg/mL at T0 (interquartile range [IQR] 38.0-142.0) to 115 pg/mL at T1 (IQR 48.0-198.0) (p < 0.05). Age (odds ratio [OR] 1.05, 95% confidence interval [CI] 1.02-1.08) and anesthesia time (OR 1.13, 95% CI 1.02-1.25) were related to stronger I-FABP increase. When comparing I-FABP change in patients experiencing any complications versus no complications, relative I-FABP change at T1 was 145% of T0 (IQR 86-260) versus 113% (IQR 44-184) respectively (p < 0.05). A significant change in I-FABP levels was seen perioperatively indicating compromised intestinal integrity. Age and anesthesia time were related to higher I-FABP increase. In patients experiencing postoperative complications, a higher I-FABP increase was found.

Sections du résumé

BACKGROUND BACKGROUND
Because of perioperative splanchnic hypoperfusion, the gut wall becomes more permeable for intraluminal microbes to enter the splanchnic circulation, possibly contributing to development of complications. Hypoperfusion-related injured enterocytes release intestinal fatty acid binding protein (I-FABP) into plasma, which is used as proxy of intestinal integrity. This study investigates the occurrence of intestinal integrity loss during oncologic surgery, measured by I-FABP change. Secondary the relationship between compromised intestinal integrity, and related variables and complications were studied.
METHODS METHODS
Patients undergoing oncologic surgery from prospective cohort studies were included. Urine I-FABP samples were collected preoperatively (T0) and at wound closure (T1), and in a subgroup on Day 1 (D1) and Day 2 (D2) postoperatively. I-FABP dynamics were investigated and logistic regression analyses were performed to study the association between I-FABP levels and patient-related, surgical variables and complications.
RESULTS RESULTS
A total of 297 patients were included with median age of 70 years. Median I-FABP value increased from 80.0 pg/mL at T0 (interquartile range [IQR] 38.0-142.0) to 115 pg/mL at T1 (IQR 48.0-198.0) (p < 0.05). Age (odds ratio [OR] 1.05, 95% confidence interval [CI] 1.02-1.08) and anesthesia time (OR 1.13, 95% CI 1.02-1.25) were related to stronger I-FABP increase. When comparing I-FABP change in patients experiencing any complications versus no complications, relative I-FABP change at T1 was 145% of T0 (IQR 86-260) versus 113% (IQR 44-184) respectively (p < 0.05).
CONCLUSIONS CONCLUSIONS
A significant change in I-FABP levels was seen perioperatively indicating compromised intestinal integrity. Age and anesthesia time were related to higher I-FABP increase. In patients experiencing postoperative complications, a higher I-FABP increase was found.

Identifiants

pubmed: 38225477
doi: 10.1245/s10434-023-14857-7
pii: 10.1245/s10434-023-14857-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019. https://doi.org/10.1002/ijc.31937 .
doi: 10.1002/ijc.31937 pubmed: 31597196 pmcid: 7470451
Sullivan R, Alatise OI, Anderson BO, et al. Global cancer surgery: delivering safe, affordable, and timely cancer surgery. Lancet Oncol. 2015. https://doi.org/10.1016/S1470-2045(15)00223-5 .
doi: 10.1016/S1470-2045(15)00223-5 pubmed: 26427363
Wilmore DW, Smith RJ, O’Dwyer ST, et al. The gut: a central organ after surgical stress. Surgery. 1998;104:917–23.
Rowlands BJ, Soong CV, Gardiner KR. The gastrointestinal tract as a barrier in sepsis. Br Med Bull. 1999. https://doi.org/10.1258/0007142991902213 .
doi: 10.1258/0007142991902213 pubmed: 10746334
Rotstein OD. Pathogenesis of multiple organ dysfunction syndrome: gut origin, protection, and decontamination. Surg Infect. 2000. https://doi.org/10.1089/109629600750018141 .
doi: 10.1089/109629600750018141
Derikx JPM, van Waardenburg DA, Thuijls G, et al. New insight in loss of gut barrier during major non-abdominal surgery. PLoS One. 2008. https://doi.org/10.1371/journal.pone.0003954 .
doi: 10.1371/journal.pone.0003954 pubmed: 19088854 pmcid: 2599890
Derikx JPM, Poeze M, van Bijnen AA, et al. Evidence for intestinal and liver epithelial cell injury in the early phase of sepsis. Shock. 2007. https://doi.org/10.1097/shk.0b013e3180644e32 .
doi: 10.1097/shk.0b013e3180644e32 pubmed: 17607153
Wesselink EM, Kappen TH, Torn HM, et al. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth. 2018. https://doi.org/10.1016/j.bja.2018.04.036 .
doi: 10.1016/j.bja.2018.04.036 pubmed: 30236233
Pelsers MMAL, Hermens WT, Glatz JFC. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta. 2005. https://doi.org/10.1016/j.cccn.2004.09.001 .
doi: 10.1016/j.cccn.2004.09.001 pubmed: 15653098
Pelsers MMAL, Namiot Z, Kisielewski W, et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem. 2003;1:1–5. https://doi.org/10.1016/S0009-9120(03)00096-1 .
doi: 10.1016/S0009-9120(03)00096-1
Schellekens DHSM, Grootjans J, Dello SAWG, et al. Plasma intestinal fatty acid-binding protein levels correlate with morphologic epithelial intestinal damage in a human translational ischemia-reperfusion model. J Clin Gastroenterol. 2014. https://doi.org/10.1097/MCG.0b013e3182a87e3e .
doi: 10.1097/MCG.0b013e3182a87e3e pubmed: 24100750
Derikx JPM, Matthijsen RA, de Bruïne AP, et al. Rapid reversal of human intestinal ischemia-reperfusion induced damage by shedding of injured enterocytes and reepithelialisation. PLoS One. 2008. https://doi.org/10.1371/journal.pone.0003428 .
doi: 10.1371/journal.pone.0003428 pubmed: 19088854 pmcid: 2599890
Derikx JP, Luyer MD, Heineman E, et al. Non-invasive markers of gut wall integrity in health and disease. World J Gastroenterol. 2010. https://doi.org/10.3748/WJG.V16.I42.5272 .
doi: 10.3748/WJG.V16.I42.5272 pubmed: 21072889 pmcid: 2980675
Plas M, Rotteveel E, Izaks GJ, et al. Cognitive decline after major oncological surgery in the elderly. Eur J Cancer. 2017. https://doi.org/10.1016/j.ejca.2017.09.024 .
doi: 10.1016/j.ejca.2017.09.024 pubmed: 29100194
Plas M, de Haan JJ, van der Wal-Huisman H, et al. The systemic impact of a surgical procedure in older oncological patients. Eur J Surg Oncol. 2019. https://doi.org/10.1016/j.ejso.2019.04.024 .
doi: 10.1016/j.ejso.2019.04.024 pubmed: 31806520
Plas M, Rutgers A, van der Wal-Huisman H, et al. The association between the inflammatory response to surgery and postoperative complications in older patients with cancer; a prospective prognostic factor study. J Geriatr Oncol. 2020. https://doi.org/10.1016/j.jgo.2020.01.013 .
doi: 10.1016/j.jgo.2020.01.013 pubmed: 32035801
Brattinga B, Rutgers A, de Haan JJ, et al. Preoperative inflammatory markers as a predictor of three-year overall survival in older cancer patients undergoing oncologic surgery. Cancers. 2021. https://doi.org/10.3390/cancers13081824 .
doi: 10.3390/cancers13081824 pubmed: 33920422 pmcid: 8069748
Mascha EJ, Yang D, Weiss S, Sessler DI. Intraoperative mean arterial pressure variability and 30-day mortality in patients having noncardiac surgery. Anesthesiology. 2015. https://doi.org/10.1097/ALN.0000000000000686 .
doi: 10.1097/ALN.0000000000000686 pubmed: 26079800
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987. https://doi.org/10.1016/0021-9681(87)90171-8 .
doi: 10.1016/0021-9681(87)90171-8 pubmed: 3805232
Clavien PA, Barkun J, de Oliveira ML, et al. The clavien-dindo classification of surgical complications: five-year experience. Ann Surg. 2009. https://doi.org/10.1097/SLA.0b013e3181b13ca2 .
doi: 10.1097/SLA.0b013e3181b13ca2 pubmed: 19809295
Stakenborg N, Gomez-Pinilla PJ, Boeckxstaens GE. Postoperative ileus: pathophysiology, current therapeutic approaches. Handb Exp Pharmacol. 2017. https://doi.org/10.1007/164_2016_108 .
doi: 10.1007/164_2016_108 pubmed: 27999957
Su’a BU, Mikaere HL, Rahiri JL, Bissett IB, Hill AG. Systematic review of the role of biomarkers in diagnosing anastomotic leakage following colorectal surgery. Br J Surg. 2017. https://doi.org/10.1002/BJS.10487 .
doi: 10.1002/BJS.10487 pubmed: 28295255
Liu X, Yu Y, Zhu S. Inflammatory markers in postoperative delirium (POD) and cognitive dysfunction (POCD): a meta-analysis of observational studies. PLoS One. 2018. https://doi.org/10.1371/JOURNAL.PONE.0195659 .
doi: 10.1371/JOURNAL.PONE.0195659 pubmed: 30596768 pmcid: 6312390
Riley RD, Hayden JA, Steyerberg EW, et al. Prognosis Research Strategy (PROGRESS) 2: prognostic factor research. PLoS Med. 2013. https://doi.org/10.1371/JOURNAL.PMED.1001380 .
doi: 10.1371/JOURNAL.PMED.1001380 pubmed: 24260027 pmcid: 3833833
Bender R, Lange S. Adjusting for multiple testing—When and how? J Clin Epidemiol. 2001. https://doi.org/10.1016/S0895-4356(00)00314-0 .
doi: 10.1016/S0895-4356(00)00314-0 pubmed: 11297884
Sekino M, Funaoka H, Sato S, et al. Intestinal fatty acid-binding protein level as a predictor of 28-day mortality and bowel ischemia in patients with septic shock: a preliminary study. J Crit Care. 2017. https://doi.org/10.1016/J.JCRC.2017.07.012 .
doi: 10.1016/J.JCRC.2017.07.012 pubmed: 28710988
van Haren FMP, Sleigh JW, Pickkers P, van der Hoeven JG. Gastrointestinal perfusion in septic shock. Anaesth Intensive Care. 2007. https://doi.org/10.1177/0310057X0703500505 .
doi: 10.1177/0310057X0703500505 pubmed: 17933153
van Haren FMP. Prognostic value of enterocyte injury in critically ill patients: No gut, no glory? Crit Care Med. 2013. https://doi.org/10.1097/CCM.0B013E318291CABB .
doi: 10.1097/CCM.0B013E318291CABB pubmed: 23979376
Timmermans K, Sir Ö, Kox M, et al. Circulating iFABP levels as a marker of intestinal damage in trauma patients. Shock. 2015. https://doi.org/10.1097/SHK.0000000000000284 .
doi: 10.1097/SHK.0000000000000284 pubmed: 25394241
Kitai T, Kim YH, Kiefer K, et al. Circulating intestinal fatty acid-binding protein (I-FABP) levels in acute decompensated heart failure. Clin Biochem. 2017. https://doi.org/10.1016/J.CLINBIOCHEM.2017.02.014 .
doi: 10.1016/J.CLINBIOCHEM.2017.02.014 pubmed: 28232029 pmcid: 5474350
Roobottom CA, Dubbins PA. Significant disease of the celiac and superior mesenteric arteries in asymptomatic patients: predictive value of Doppler sonography. AJR Am J Roentgenol. 1993. https://doi.org/10.2214/ajr.161.5.8273642 .
doi: 10.2214/ajr.161.5.8273642 pubmed: 8273642
Gnanapandithan K, Feuerstadt P. Mesenteric ischemia. Curr Gastroenterol Rep. 2020. https://doi.org/10.1007/S11894-020-0754-X .
doi: 10.1007/S11894-020-0754-X pubmed: 32185509
Achilli P, Mazzola M, Bertoglio CL, et al. Preoperative immunonutrition in frail patients with colorectal cancer: an intervention to improve postoperative outcomes. Int J Colorectal Dis. 2020. https://doi.org/10.1007/S00384-019-03438-4 .
doi: 10.1007/S00384-019-03438-4 pubmed: 31754818
Carli F, Bousquet-Dion G, Awasthi R, et al. Effect of multimodal prehabilitation vs. postoperative rehabilitation on 30-day postoperative complications for frail patients undergoing resection of colorectal cancer: a randomized clinical trial. JAMA Surg. 2019. https://doi.org/10.1001/JAMASURG.2019.5474 .
doi: 10.1001/JAMASURG.2019.5474 pubmed: 30725090
Vermeulen Windsant IC, Hellenthal FA, Derikx JPM, et al. Circulating intestinal fatty acid-binding protein as an early marker of intestinal necrosis after aortic surgery: a prospective observational cohort study. Ann Surg. 2012. https://doi.org/10.1097/SLA.0b013e31824b1e16 .
doi: 10.1097/SLA.0b013e31824b1e16 pubmed: 22367448
Bingold TM, Franck K, Holzer K, et al. Intestinal fatty acid binding protein: a sensitive marker in abdominal surgery and abdominal infection. Surg Infect. 2015. https://doi.org/10.1089/sur.2014.073 .
doi: 10.1089/sur.2014.073
Zou L, Song X, Hong L, et al. Intestinal fatty acid-binding protein as a predictor of prognosis in postoperative cardiac surgery patients. Medicine. 2018. https://doi.org/10.1097/MD.0000000000011782 .
doi: 10.1097/MD.0000000000011782 pubmed: 30544386 pmcid: 6310604
Kho ME, Duffett M, Willison DJ, et al. Written informed consent and selection bias in observational studies using medical records: systematic review. BMJ. 2009. https://doi.org/10.1136/BMJ.B866 .
doi: 10.1136/BMJ.B866 pubmed: 19282440 pmcid: 2769263

Auteurs

Sharon Hendriks (S)

Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. s.hendriks@umcg.nl.

Monique G Huisman (MG)

Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Suzanne C Stokmans (SC)

Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Matthijs Plas (M)

Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Hanneke van der Wal-Huisman (H)

Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Barbara C van Munster (BC)

Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Anthony R Absalom (AR)

Department of Anesthesiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Gertrude J Nieuwenhuijs-Moeke (GJ)

Department of Anesthesiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Geertruida H de Bock (GH)

Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Barbara L van Leeuwen (BL)

Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Jacco J de Haan (JJ)

Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Classifications MeSH